We are live on
!
Find out more
FP
Factorial Partners Portfolio holdings
AUM
$138M
1-Year Est. Return
25.59%
This Fund
S&P 500
This Quarter
Est. Return
+24.15%
1 Year Est. Return
+25.59%
3 Year Est. Return
+78.35%
5 Year Est. Return
+78.52%
10 Year Est. Return
–
AUM
$91.3M
AUM Growth
+$16.3M
(+22%)
Cap. Flow
+$1.42M
Cap. Flow
% of AUM
1.56%
Top 10 Holdings %
Top 10 Hldgs %
33.43%
Holding
111
New
8
Increased
35
Reduced
18
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Globe Life
GL
|
+$1.57M |
| 2 |
American Express
AXP
|
+$1.38M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.21M |
| 4 |
J.M. Smucker
SJM
|
+$888K |
| 5 |
Toll Brothers
TOL
|
+$681K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.72M |
| 2 |
MGIC Investment
MTG
|
+$905K |
| 3 |
Goldman Sachs
GS
|
+$817K |
| 4 |
Delta Air Lines
DAL
|
+$793K |
| 5 |
CSX Corp
CSX
|
+$790K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 32.34% |
| 2 | Healthcare | 18.48% |
| 3 | Consumer Discretionary | 14.23% |
| 4 | Industrials | 13.55% |
| 5 | Technology | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Merit Medical Systems
MMSI
$4.43B
| – | – |
-2,100
| Closed | -$65.6K |
|
102
Merck
MRK
$324B
| – | – |
-2,934
| Closed | -$215K |
|
|
ACH
103
Accendra Health
ACH
$240M
| – | – |
-48,000
| Closed | -$439K |
|
104
OneSpan
OSPN
$562M
| – | – |
-1,000
| Closed | -$18.1K |
|
105
OraSure Technologies
OSUR
$273M
| – | – |
-60,000
| Closed | -$646K |
|
106
Synaptics
SYNA
$4.41B
| – | – |
-2,600
| Closed | -$150K |
|
|
TGI
107
DELISTED
Triumph Group
TGI
| – | – |
-23,000
| Closed | -$155K |
|
108
Unum
UNM
$13.8B
| – | – |
-6,000
| Closed | -$90.1K |
|
|
VIVO
109
DELISTED
Meridian Bioscience Inc
VIVO
| – | – |
-7,877
| Closed | -$66.2K |
|
|
TPCO
110
DELISTED
Tribune Publishing Company Common Stock
TPCO
| – | – |
-18,000
| Closed | -$146K |
|
Similar funds
TC
PBRA
DFS
LPAM
CI
ACA
LIA
CW
Factorial Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Factorial Partners held 111 positions worth $91.3M, up 22% from $75M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Factorial Partners's Q2 2020 filing shows 8 new, 35 increased, 18 reduced and 16 closed positions. Its largest new stake was Globe Life: 20,700 shares worth $1.54M. The largest sale was Gilead Sciences, an estimated $1.72M.
By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Factorial Partners's largest Q2 2020 buy was Globe Life: 20,700 shares worth $1.54M.
- Factorial Partners added most to American Express in Q2 2020, an estimated $1.38M increase.
- Factorial Partners's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $1.72M.
- Factorial Partners fully exited Delta Air Lines in Q2 2020, selling an estimated $793K.
- Factorial Partners's ten largest holdings make up 33% of its $91.3M portfolio in Q2 2020.
- Factorial Partners opened 8 new positions and closed 16 in Q2 2020.
- Factorial Partners's portfolio value rose 22% quarter-over-quarter to $91.3M.
Based on Factorial Partners's 13F filing for Q2 2020, filed 13 Aug 2020.